Artificial intelligence could help prevent transplant complications by personalizing drug dosing
NCT ID NCT07695571
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This study aims to develop an artificial intelligence tool that helps doctors choose the right dose of cyclosporine for patients who have received a bone marrow transplant. Cyclosporine is used to prevent graft-versus-host disease, a serious complication where donor cells attack the patient's body. The tool combines information about how the drug behaves in the body with machine learning and deep learning techniques to predict the best dose using minimal blood samples. The goal is to make dosing more personalized and practical for everyday clinical care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cyclosporine
- What this could lead to
- If successful, this AI tool could help doctors personalize cyclosporine doses for each patient, potentially reducing the risk of graft-versus-host disease after bone marrow transplant.
- What could go wrong
- This is a modeling study, not a treatment trial. The tool's predictions may not improve real-world outcomes, and its accuracy depends on the quality of the data used.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pressurized oxygen boost cord blood transplants?
- Personalized leukemia vaccine aims to outsmart relapse
- Supercharged donor cells aim to stop leukemia return after transplant
- New drug aims to wake up immune system against Hard-to-Treat leukemia
- Experimental CAR-T therapy takes on tough leukemia
- Can a dialysis-like treatment save kids with lung failure after transplant?